Q4 2023 Holdings
Filed 2024-02-14 | 70 holdings | $4.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $57.7M | 8,748,629 | 1.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $60.3M | 10,400,158 | 1.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $61.0M | 5,870,000 | 1.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $61.5M | 1,729,043 | 1.5% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $67.2M | 3,633,743 | 1.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $69.8M | 8,774,570 | 1.7% |
| AC Immune SA(ACIU) | SHS | H00263105 | $72.9M | 14,571,236 | 1.8% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $75.4M | 10,333,600 | 1.9% |
| Merus N V | COM | N5749R100 | $75.7M | 2,752,420 | 1.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $77.8M | 1,915,109 | 1.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $81.2M | 4,007,413 | 2.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $106.0M | 7,373,228 | 2.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $122.9M | 2,428,613 | 3.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $128.2M | 9,135,893 | 3.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $129.0M | 4,370,024 | 3.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $131.4M | 5,161,801 | 3.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $131.7M | 5,744,848 | 3.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $157.7M | 1,981,100 | 3.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $171.5M | 5,981,212 | 4.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.3B | 21,751,284 | 32.9% |